GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (OTCPK:RKVTF) » Definitions » Cash Receipts from Operating Activities

RKVTF (Rakovina Therapeutics) Cash Receipts from Operating Activities


View and export this data going back to 2024. Start your Free Trial

What is Rakovina Therapeutics Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Rakovina Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
105 1008 Beach Avenue, Vancouver, BC, CAN, V6E 1T7
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before. The company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners.